These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21789006)

  • 41. Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis.
    Chai YJ; Kim SJ; Choi JY; Koo do H; Lee KE; Youn YK
    World J Surg; 2014 Jun; 38(6):1306-11. PubMed ID: 24366273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
    Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The localization of thyroid cancers on the thyroid gland is a new risk factor for metastases of perithyroidal, peritracheal and central lymph nodes.
    Ocak ÖK; Ergenc H; Ergenc Z; Gökosmanoğlu F
    Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4017-4022. PubMed ID: 35357577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Solitary lateral neck node metastasis in papillary thyroid carcinoma.
    Kim SM; Chun KW; Chang HJ; Kim BW; Lee YS; Chang HS; Park CS
    World J Surg Oncol; 2014 Apr; 12():109. PubMed ID: 24755464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
    Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
    Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Importance of lymph node metastases in follicular thyroid cancer.
    Witte J; Goretzki PE; Dieken J; Simon D; Röher HD
    World J Surg; 2002 Aug; 26(8):1017-22. PubMed ID: 12045860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks.
    Ito Y; Miyauchi A
    World J Surg; 2007 May; 31(5):905-15. PubMed ID: 17219265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Significance of selective neck dissection in patients with cN0 thyroid carcinoma].
    Li ZJ; An CM; Yan DG; Zhang XW; Zhang ZM; Xu ZG; Tang PZ
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):783-6. PubMed ID: 24378103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk Factors for Nodal Metastasis in cN0 Papillary Thyroid Microcarcinoma.
    Zhang LY; Liu ZW; Liu YW; Gao WS; Zheng CJ
    Asian Pac J Cancer Prev; 2015; 16(8):3361-3. PubMed ID: 25921145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequency and predictive factors of malignancy in residual thyroid tissue and cervical lymph nodes after partial thyroidectomy for differentiated thyroid cancer.
    Alzahrani AS; Al Mandil M; Chaudhary MA; Ahmed M; Mohammed GE
    Surgery; 2002 Apr; 131(4):443-9. PubMed ID: 11935135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LYMPHOCYTIC THYROIDITIS IS ASSOCIATED WITH INCREASED NUMBER OF BENIGN CERVICAL NODES AND FEWER CENTRAL NECK COMPARTMENT METASTATIC LYMPH NODES IN PATIENTS WITH DIFFERENTIATED THYROID CANCER.
    Donangelo I; Walts AE; Bresee C; Braunstein GD
    Endocr Pract; 2016 Oct; 22(10):1192-1198. PubMed ID: 27732096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence and significance of Delphian node metastasis in papillary thyroid cancer.
    Iyer NG; Kumar A; Nixon IJ; Patel SG; Ganly I; Tuttle RM; Shah JP; Shaha AR
    Ann Surg; 2011 May; 253(5):988-91. PubMed ID: 21372688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Current TNM system of the UICC/AJCC : the prognostic significance for differentiated thyroid carcinoma].
    Stratmann M; Sekulla C; Dralle H; Brauckhoff M
    Chirurg; 2012 Jul; 83(7):646-51. PubMed ID: 22273853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 cases.
    Bozec A; Dassonville O; Chamorey E; Poissonnet G; Sudaka A; Peyrottes I; Ettore F; Haudebourg J; Bussière F; Benisvy D; Marcy PY; Sadoul JL; Hofman P; Lassale S; Vallicioni J; Demard F; Santini J
    Eur Arch Otorhinolaryngol; 2011 Aug; 268(8):1205-1212. PubMed ID: 21607578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases.
    Lin JD; Liou MJ; Chao TC; Weng HF; Ho YS
    Endocr Relat Cancer; 1999 Mar; 6(1):109-15. PubMed ID: 10732793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
    Linder R; Fuhrmann J; Hammerschmidt D
    Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Lymph nodes metastases in differentiated thyroid cancer--prognostic value and syrgical results with 430 patients for 30 years period (1980-2010)].
    Petkov R; Katev N; Todorov G; Mladenovski V; Yaramov N; Sokolov M
    Khirurgiia (Sofiia); 2011; (3):24-7. PubMed ID: 23844459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Review of distribution of nodal disease in differentiated thyroid cancers in an oncosurgical center in Sri Lanka.
    Amarasinghe IY; Perera NM; Bahinathan N; Marzook HH; Peiris AK
    Ann Surg Oncol; 2007 May; 14(5):1560-4. PubMed ID: 17318279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin.
    Nilubol N; Zhang L; Kebebew E
    Thyroid; 2013 Jun; 23(6):695-702. PubMed ID: 23194434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.